News ASH: Stem cell transplant study exposes US zip-code lottery Access to a stem cell transplant in the US - and the chances of surviving it - depends on social and economic factors, finds a new study.
Partner Content Partner Content COUCH Health Finds Reasons Behind Underrepresentation of Min... New research shows how to improve trial diversity
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face